$CELG Form 8-K

ITEM 8.01 OTHER EVENTS.On June 17, 2015, Celgene Corporation (the “Company”) issued a press release announcing the authorization of the repurchase of up to an additional $4.0 billion of the Company’s common stock. Purchases may be made in the open market or in privately negotiated transactions from time to time, as determined by Celgene’s management and in accordance with the requirements of the Securities and Exchange Commission. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.